144 related articles for article (PubMed ID: 23995360)
1. Development of a novel and simple method to evaluate disintegration of rapidly disintegrating tablets.
Hoashi Y; Tozuka Y; Takeuchi H
Chem Pharm Bull (Tokyo); 2013; 61(9):962-6. PubMed ID: 23995360
[TBL] [Abstract][Full Text] [Related]
2. A new method for disintegration studies of rapid disintegrating tablet.
Narazaki R; Harada T; Takami N; Kato Y; Ohwaki T
Chem Pharm Bull (Tokyo); 2004 Jun; 52(6):704-7. PubMed ID: 15187391
[TBL] [Abstract][Full Text] [Related]
3. Assessment of disintegration of rapidly disintegrating tablets by a visiometric liquid jet-mediated disintegration apparatus.
Desai PM; Liew CV; Heng PW
Int J Pharm; 2013 Feb; 442(1-2):65-73. PubMed ID: 22985772
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test.
Harada T; Narazaki R; Nagira S; Ohwaki T; Aoki S; Iwamoto K
Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1072-5. PubMed ID: 16880646
[TBL] [Abstract][Full Text] [Related]
5. Clinical disintegration time of orally disintegrating tablets clinically available in Japan in healthy volunteers.
Yoshita T; Uchida S; Namiki N
Biol Pharm Bull; 2013; 36(9):1488-93. PubMed ID: 23995661
[TBL] [Abstract][Full Text] [Related]
6. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration.
Abdelbary G; Eouani C; Prinderre P; Joachim J; Reynier J; Piccerelle P
Int J Pharm; 2005 Mar; 292(1-2):29-41. PubMed ID: 15725551
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
[TBL] [Abstract][Full Text] [Related]
8. Development of a new disintegration method for orally disintegrating tablets.
Kakutani R; Muro H; Makino T
Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):885-90. PubMed ID: 20606331
[TBL] [Abstract][Full Text] [Related]
9. Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets.
Koner JS; Rajabi-Siahboomi AR; Missaghi S; Kirby D; Perrie Y; Ahmed J; Mohammed AR
Sci Rep; 2019 Aug; 9(1):12467. PubMed ID: 31462654
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of disintegration properties of orally rapidly disintegrating tablets using a novel disintegration tester.
Kondo K; Niwa T; Danjo K
Chem Pharm Bull (Tokyo); 2012; 60(10):1240-8. PubMed ID: 23036967
[TBL] [Abstract][Full Text] [Related]
11. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
Hooper P; Lasher J; Alexander KS; Baki G
J Pharm Biomed Anal; 2016 Feb; 120():391-6. PubMed ID: 26774944
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of disintegrating time of rapidly disintegrating tablets by a paddle method.
Que L; Wu W; Cheng X; Hu T
Pharm Dev Technol; 2006; 11(3):295-301. PubMed ID: 16895840
[TBL] [Abstract][Full Text] [Related]
13. The preparation of rapidly disintegrating tablets in the mouth.
Sugimoto M; Matsubara K; Koida Y; Kobayashi M
Pharm Dev Technol; 2001 Nov; 6(4):487-93. PubMed ID: 11775950
[TBL] [Abstract][Full Text] [Related]
14. Applicability of two automated disintegration apparatuses for rapidly disintegrating (mini)tablets.
Sieber D; Lazzari A; Quodbach J; Pein M
Pharm Dev Technol; 2017 Mar; 22(2):198-205. PubMed ID: 27268966
[TBL] [Abstract][Full Text] [Related]
15. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy.
Goodman K; Hodges LA; Band J; Stevens HN; Weitschies W; Wilson CG
Eur J Pharm Biopharm; 2010 Jan; 74(1):84-92. PubMed ID: 19602377
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
Bi Y; Sunada H; Yonezawa Y; Danjo K; Otsuka A; Iida K
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2121-7. PubMed ID: 8945778
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera.
Morita Y; Tsushima Y; Yasui M; Termoz R; Ajioka J; Takayama K
Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1181-6. PubMed ID: 12237533
[TBL] [Abstract][Full Text] [Related]
18. A novel method for predicting disintegration time in the mouth of rapidly disintegrating tablet by compaction analysis using TabAll.
Shibata Y; Yamamoto Y; Fujii M; Kondoh M; Watanabe Y
Chem Pharm Bull (Tokyo); 2004 Nov; 52(11):1394-5. PubMed ID: 15516774
[TBL] [Abstract][Full Text] [Related]
19. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
[TBL] [Abstract][Full Text] [Related]
20. Characterising the disintegration properties of tablets in opaque media using texture analysis.
Scheuerle RL; Gerrard SE; Kendall RA; Tuleu C; Slater NK; Mahbubani KT
Int J Pharm; 2015; 486(1-2):136-43. PubMed ID: 25791759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
